Enzymatic vitreolysis with recombinant microplasminogen and tissue plasminogen activator

Eye

Volumn 22, Issue 2, 2008, Pages 300-307

  Chen, W ^a   Huang, X ^b   Ma, X W ^a   Mo, W ^a   Wang, W J ^b   Song, H Y ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; BALANCED SALT SOLUTION; PLASMIN; PLASMINOGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B SCAN; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYMATIC ASSAY; ENZYME ACTIVATION; FEMALE; INCUBATION TIME; INTERMETHOD COMPARISON; MALE; NEW ZEALAND; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; RABBIT; RETINA; SCANNING ELECTRON MICROSCOPY; TEMPERATURE MEASUREMENT; VITREOUS BODY DETACHMENT;

EID: 39449103901     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6702931     Document Type: Article

References (29)

1. Han DP, Abrams GW, Aaberg TM. Surgical excision of the attached posterior hyaloid. Arch Ophthalmol 1998, 106: 998-1000.
2. Vander JF, Kleiner R. A method for induction of posterior vitreous detachment during vitrectomy. Retina 1992; 12: 172-173.
3. Sebag J. Age-related changes in human vitreous structure. Graefes Arch Clin Exp Ophthalmol 1987; 225: 89-93.
4. Lewis H, Abrams GW, Blumenkranz MS, Campo RV. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology 1992; 99: 753-759.
5. Hageman GS, Russell SR. Chondroitinase mediated disinsertion of the primate vitreous body. Invest Ophthalmol Vis Sci 1994; 35 Suppl): 1260.
6. Harooni M, Mchillan T, Refojo M. Efficacy and safety of enzymatic posterior vitreous detachment by intravitreal injection of hyaluronidase. Retina 1998; 18: 16-22.
7. Zhang YZ, Lee HZ. Quantitative changes in the glomerular basement membrane components in human membranous nephropathy. J Pathol 1997; 183: 8-15.
8. Tezel TH, Del Priore LV, Kaplan HJ. Posterior vitreous detachment with dispase. Retina 1998; 18: 7-15.
9. Oliveira LB, Tatebayashi M, Mahmoud TH, Blackmon SM, Wong F, McCuen BW. Dispase facilitates posterior vitreous detachment during vitrectomy in young pigs. Retina 2001; 21: 324-331.
10. Verstraeten TC, Chapman C, Hartzer M, Winkler BS, Trese MT, Williams GA. Pharmacologic induction of posterior vitreous detachment in the rabbit. Arch Ophthalmol 1993; 111: 849-854.
11. Gandorfer A, Ulbig M, Kampic A. Plasmin-assisted vitrectomy eliminates cortical vitreous remnants. Eye 2002; 16: 95-97.
12. Gandorfer A, Priglinger S, Schebitz K, Hoops J, Ulbig M, Ruckhofer J et al. Vitreoretinal morphology of plasmin-treated human eyes. Am J Ophthalmol 2002; 133: 156-159.
13. Li X, Shi X, Fan J. Posterior vitreous detachment with plasmin in the isolated human eye. Graefes Arch Clin Exp Ophthalmol 2002; 240 56-62.
14. Wu HL, Shi GY, Wohl RC. Preparation and purification of microplasmin. Proc Natl Acad Sci USA 1987; 84: 8292-8295.
15. Lapchak PA, Araujo DM, Pakola S, Song D, Wei J, Zivin JA. Microplasmin: a novel thrombolytic that improves behavioral outcome after embolic stroke in rabbits. Stroke 2002; 33: 2279-2284.
16. Lapchak PA. Development of thrombolytic therapy for stroke: A perspective. Expert Opin Investig Drugs 2002; 11: 1623-1632.
17. Nagai N, Demarsin E, Van HB. Recombinant human microplasin: Production and potential therapeutic properties. J Thro Haem 2003; 1: 307-313.
18. Trese MT, Williams GA, Hartzer MK. A new approach to stage 3 macular holes. Ophthalmology 2000; 107: 1607-1611.
19. Wang ZL, Zhang X, Xu X, Sun XD, Wang F. PVD following plasmin but not hyaluronidase: Implications for combination pharmacologic vitreolysis therapy. Retina 2005; 25: 38-43.
20. Hikichi T, Yanagiya N, Kado M, Akiba J, Yoshida A. Posterior vitreous detachment induced by injection of plasmin and sulfur hexafluoride in the rabbit vitreous. Retina 1999; 19: 55-58.
21. Gandorfer A, Putz E, Welge-Lussen U, Gruterich M, Ulbig M, Kampik A. Ultrastrurture of the vitreoretinal interface following plasmin assisted vitrectomy. Br J Ophthalmol 2001; 85: 6-10.
22. Williams JG, Trese MT, Williams GA, Hartzer MK. Autologous plasmin enzyme in the surgical management of diabetic retinopathy. Ophthalmology 2001; 108: 1902-1905.
23. Le Mer Y, Korobelnik JF, Morel C, Ullern M, Berrod JP. TPA-assisted vitrectomy for proliferative diabetic retinopathy: Results of a double-masked, multicenter trial. Retina 1999; 19: 378-382.
24. Hesse L, Nebeling B, Schroeder B, Heller G, Kroll P. Induction of posterior vitreous detachment in rabbits by intravitreal injection of tissue plasminogen activator following cryopexy. Exp Eye Res 2000; 70: 31-39.
25. Unal M, Peyman GA. The efficacy of plasminogen-urokinase combination in inducing posterior vitreous detachment. Retina 2000; 20: 69-75.
26. Hrach JH, Jonshon MW, Hassan AS, Lei B, Sieving PA, Elner VM. Retinal toxicity of commercial intravitreal tissue plasminogen activator solution in cat eyes. Arch Ophthalmol 2000; 118: 659-663.
27. Gandorfer A, Rohleder M, Sethi C, Eckle D, Welge-Lussen U, Kampik A et al. Posterior vitreous detachment induced by microplasmin. Invest Ophthalmol Vis Sci 2004; 45: 641-647.
28. Sakamoto T, Miyazaki M, Hisatomi T, Nakamura T, Ueno A, Itaya K et al Triamcinoclone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown. Greafes Arch Clin Exp Ophthalmol 2002; 240: 423-429.
29. Matsumoto B, Blanks JC, Ryan SJ. Topographic variations in the rabbit and primate internal limiting membrane. Invest Ophthalmol Vis Sci 1984; 25: 71-82.